A systematic review of oral fungal infections in patients receiving cancer therapy. - Test2 - elhamkhani - TriplyDB

A systematic review of oral fungal infections in patients receiving cancer therapy.

A systematic review of oral fungal infections in patients receiving cancer therapy.

http://www.wikidata.org/entity/Q30431307

about

Alternative approaches to antifungal therapies Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Oral complications in hematopoietic stem cell recipients: the role of inflammation First human model of in vitro Candida albicans persistence within granuloma for the reliable study of host-fungi interactions Candidiasis (oropharyngeal).Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Urban legends series: oral candidosis.Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols Miconazole mucoadhesive tablet for oropharyngeal candidiasis Candida species distribution, genotyping and virulence factors of Candida albicans isolated from the oral cavity of kidney transplant recipients of two geographic regions of Brazil.Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy Invitro Anti-mycotic Activity of Hydro Alcoholic Extracts of Some Indian Medicinal Plants against Fluconazole Resistant Candida albicans Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole Investigation of the oral infections and manifestations seen in patients with advanced cancer.Oral health conditions affect functional and social activities of terminally ill cancer patients Oral complications in the treatment of cancer patients.Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.The role of the general dental practitioner in managing the oral care of head and neck oncology patients.Pathogenicity mechanisms and host response during oral Candida albicans infections.Candida albicans and cancer: Can this yeast induce cancer development or progression?International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis.Fungal contribution in chondroradionecrosis of the larynx.Serious fungal infections in Canada.Serious fungal infections in Korea.Mining the oral mycobiome: Methods, components, and meaning.The significance of Candida in the human respiratory tract: our evolving understanding.Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients.TNF as marker of oral candidiasis, HSV infection, and mucositis onset during chemotherapy in leukemia patients.Estimated burden of fungal infections in Germany.Pain management during radiotherapy and radiochemotherapy in oropharyngeal cancer patients: single-institution experience.Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.Influence of cancer treatment on the Candida albicans isolated from the oral cavities of cancer patients.Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.The effect of eating sea cucumber jelly on Candida load in the oral cavity of elderly individuals in a nursing home Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern.Oral evaluation and procedures performed by dentists in patients admitted to the intensive care unit of a cancer center.

P2860

Q26999896-0C1776F9-54F4-493C-A061-12B21A09B718 Q27026718-DC1B6231-2CA4-4743-A0EA-10D5EE74D0B3 Q27027650-7F8FCF21-1A9F-4804-B4F9-B58BE4E48359 Q27335343-25F1812D-FE91-46F7-9A54-C6EF4997D6B0 Q34164044-1A925494-4F3A-446E-BDBC-202B9C00812C Q34299445-89B110DF-790C-4B21-AD13-38F0D72A19FC Q34301094-FFE441D5-427C-4904-B3D3-A15A8EBDC616 Q34346429-3C1E93AD-57E4-41A7-8037-39DFA84AF4FA Q34795361-6A42812D-9BB6-439F-A2D4-2E7FB3CDF6AD Q35120639-A417DB0C-C859-4326-A448-61735773FEAF Q35147193-02CFB3DD-2A32-499C-9CBE-DD76483F723F Q35238239-A95D45A6-E6F2-45AA-BF96-D74F3509286C Q36077588-7F4F2C46-60E6-48F3-B7E2-5762C690523B Q36345473-6050814F-78F1-4CEB-BB3B-FD3726C64646 Q37261224-29BBD82C-2F9E-4AFB-A2A9-EE213E29A5D5 Q37382634-D5C3D703-33F2-42DA-84C3-C61C5567354F Q37656258-F9E2AF12-9AF2-4EFB-818A-FB381D5F0CDA Q37838501-2AAE9770-3213-4922-941C-4A1515CF02A9 Q37863536-36847074-E3D9-475C-8B3C-A6E0A484C0EA Q37998072-D6D1715B-2284-4AF3-866E-0A2E5E88AC47 Q38077984-FEF2719C-3236-4BAA-BE31-F0124B031FB6 Q38209882-ECEED0C9-E149-4473-A69A-43CB97F65D03 Q38223120-12BEA4B0-7552-41DA-AC5D-B91E78DDC377 Q38393256-604909A3-4B79-4B14-A044-76966A20C44D Q38604392-BBA79B82-B4CD-4863-8499-4A610AA7716D Q38964050-311B8E98-502F-4ED5-A72F-B63B19DF33DC Q38978705-EB145B39-31C8-4255-8971-2C4D6016DEB4 Q38978715-74B724A9-8F61-48A6-BEFC-EC0648386542 Q38993561-4F6702FB-71E6-43F5-B6DA-1E6A4F0103D0 Q39250702-584BB672-FCB5-426C-B827-99A7D7DF1115 Q39337642-F97192F7-0A0A-4383-A2E5-EA81FF32BD7C Q40245483-FA4D8F53-B954-4A4E-B87E-0E495266E948 Q40451809-C5CCF6BD-4323-456E-972A-1AD5F7B9D24E Q40547962-2C3CBE42-8D23-41A9-98DC-7A6640E1F71A Q40787455-66FB0541-68D0-498A-9A72-9DAD3E3F8C4B Q40882454-648CD9EB-4557-4591-8C9C-EA5DE15F9479 Q41085151-C3100CF5-95A6-43CE-88CB-38EB90F62465 Q41845327-70CF2B6A-F410-48D9-AD69-C5495D6AE7C7 Q42082711-258F4176-ADB8-4280-B2B9-535DCF6F654D Q43791571-59488B3A-1B3A-448C-9D34-7EE7DB282E76

P2860

A systematic review of oral fungal infections in patients receiving cancer therapy.

http://www.wikidata.org/entity/Q30431307

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A systematic review of oral fungal infections in patients receiving cancer therapy.

@ast

A systematic review of oral fungal infections in patients receiving cancer therapy.

@en

type

label

A systematic review of oral fungal infections in patients receiving cancer therapy.

@ast

A systematic review of oral fungal infections in patients receiving cancer therapy.

@en

prefLabel

A systematic review of oral fungal infections in patients receiving cancer therapy.

@ast

A systematic review of oral fungal infections in patients receiving cancer therapy.

@en

P1433

Q30431307-80EC2EB8-7046-4955-AE03-81039EFB6616

P1476

Q30431307-1A54002A-FB77-43CE-B20D-585C3DCD2E3D

P2093

Q30431307-51AFD111-FCA8-4812-A576-63D7E1863836

Q30431307-5ECED6F5-224D-4C1B-B9D8-48A727B53241

Q30431307-6185F9DA-F8D0-47C9-B67A-180512E81434

Q30431307-8892E114-8923-4B33-88FB-4D8B934F1076

Q30431307-9153DE0F-9575-4294-BA5D-37788E653143

Q30431307-9186CFB6-D67D-48E6-AB0D-840A2CDCE923

Q30431307-A7DAB95F-D461-4E72-8E15-BA00F6CE1A99

Q30431307-C524AAD9-637A-4D19-9091-F4DA7322705C

Q30431307-C69BC0F2-C3FE-4631-8869-1855CFDC04A2

Q30431307-DD44F0A5-5F71-469E-9C6D-4FEC2879FB67

P2860

Q30431307-0976C038-C4C9-4DDE-9425-E764E3034C99

Q30431307-17A10F4D-A7B3-4170-9514-5B7E89AD020A

Q30431307-1E772207-0773-41F5-A770-1DB7E7CFE2CB

Q30431307-25C966B0-01C6-4E98-AC90-0AEC959A5300

Q30431307-29E6A696-B174-4370-B85E-AB493711C6B1

Q30431307-2C18F9DD-0410-48D5-9694-3556486B9CAF

Q30431307-344E9EF6-13E6-44D2-B5FA-471453038026

Q30431307-3AE70060-75AD-4A33-838E-AE8174347DD0

Q30431307-3E723490-77BA-4066-A73D-C93C88909CB1

Q30431307-46136E36-AA17-46DE-B3B7-57DE552BF908

P2888

Q30431307-E4842A0B-BA8D-47CB-AC8E-62A90B3C9DD0

P304

Q30431307-E4C6F905-F33A-4AFD-992A-32C55ED9DFDB

P31

Q30431307-97541D59-249B-4C02-AE62-E0C6F88795C9

Q30431307-F5AE0004-DCF7-43D7-B614-F4493C8A2867

P356

Q30431307-6F1AD07E-2948-40D0-B3B0-30243E723BEC

P433

Q30431307-2821A3FD-C9B7-45AC-8DD8-184C8938D99B

P478

Q30431307-0032B05F-A636-4C3D-A751-4EAD446FFBEF

P50

Q30431307-4B9F1E00-374F-4A5A-A489-DBB4B1F64D59

Q30431307-51AEEEA8-A0DF-4F6E-9B78-A73631195500

Q30431307-D1AA4D9C-E3D4-4480-99B6-44BB274B08B8

P577

Q30431307-966BDDFD-5EEF-4969-BBC2-56F334D38E75

P5875

Q30431307-246A38E2-A0FC-4F45-9F94-5AD2CF8687A6

P698

Q30431307-B378F3B9-70C1-400B-8E72-B97282637728

P932

Q30431307-79CA6EED-0A7F-4083-9D16-2A79BB4911C2

P356

S00520-010-0892-Z

P1433

Supportive Care in Cancer

P1476

A systematic review of oral fungal infections in patients receiving cancer therapy

@en

P2093

Andrew Martof

http://www.w3.org/2001/XMLSchema#string

Dena J Fischer

http://www.w3.org/2001/XMLSchema#string

Fred K L Spijkervet

http://www.w3.org/2001/XMLSchema#string

Fungal Infections Section, Ora ...... ociety of Oral Oncology (ISOO)

http://www.w3.org/2001/XMLSchema#string

Linda S Elting

http://www.w3.org/2001/XMLSchema#string

Marie C Latortue

http://www.w3.org/2001/XMLSchema#string

Michael T Brennan

http://www.w3.org/2001/XMLSchema#string

Ourania Nicolatou-Galitis

http://www.w3.org/2001/XMLSchema#string

Rajesh V Lalla

http://www.w3.org/2001/XMLSchema#string

Sandra D'Amato-Palumbo

http://www.w3.org/2001/XMLSchema#string

P2860

A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.

Chemotherapy-associated oral mucosal lesions in patients with leukaemia or lymphoma.

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors.

Oral complications and management considerations in patients treated with high-dose chemotherapy.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.

Management of patients who have undergone head and neck cancer therapy.

Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature.

Infection prevention in bone marrow transplantation and radiation patients.

P2888

s00520-010-0892-z

P304

985-992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1007/S00520-010-0892-Z

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Lauren L. Patton

Anura Ariyawardana

P577

2010-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44579990

http://www.w3.org/2001/XMLSchema#string

P698

20449755

http://www.w3.org/2001/XMLSchema#string

P932

2914797

http://www.w3.org/2001/XMLSchema#string